Contrasting Sotera Health (SHC) & Its Rivals

Sotera Health (NYSE: SHC) is one of 27 public companies in the “Miscellaneous health & allied services, not elsewhere classified” industry, but how does it weigh in compared to its rivals? We will compare Sotera Health to related businesses based on the strength of its risk, valuation, profitability, institutional ownership, dividends, earnings and analyst recommendations.

Earnings & Valuation

This table compares Sotera Health and its rivals top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Sotera Health $818.16 million -$38.62 million 64.37
Sotera Health Competitors $1.94 billion $96.17 million 42.17

Sotera Health’s rivals have higher revenue and earnings than Sotera Health. Sotera Health is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Institutional & Insider Ownership

87.6% of Sotera Health shares are owned by institutional investors. Comparatively, 43.2% of shares of all “Miscellaneous health & allied services, not elsewhere classified” companies are owned by institutional investors. 65.0% of Sotera Health shares are owned by insiders. Comparatively, 26.4% of shares of all “Miscellaneous health & allied services, not elsewhere classified” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.


This table compares Sotera Health and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Sotera Health N/A N/A N/A
Sotera Health Competitors -39.15% 16.05% -9.95%

Analyst Recommendations

This is a breakdown of current ratings and target prices for Sotera Health and its rivals, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sotera Health 0 0 10 0 3.00
Sotera Health Competitors 92 389 536 15 2.46

Sotera Health presently has a consensus price target of $32.15, suggesting a potential upside of 31.44%. As a group, “Miscellaneous health & allied services, not elsewhere classified” companies have a potential upside of 8.00%. Given Sotera Health’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Sotera Health is more favorable than its rivals.


Sotera Health beats its rivals on 8 of the 12 factors compared.

About Sotera Health

Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the Americas, Europe and Asia. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with's FREE daily email newsletter.